Angiogenesis, the formation of new blood vessels, is a crucial stage of the wound-healing process. In chronic wounds, reduced microvascular regeneration causes inflammation and oxygen shortage [
79]. This leads to a persistent inflammatory response and hinders the transition of wounds from inflammation to healing phases [
80]. Enhancing angiogenesis proves effective in treating metabolic issues and reducing inflammation by improving tissue oxygenation and nutrient supply for better wound healing [
79]. Copper is crucial for wound healing, influencing growth factors like platelet-derived growth factor (PDGF), and vascular endothelial growth factor (VEGF), and angiopoietin. It aids by boosting collagen deposition and acting as an antibacterial agent [
81]. Research suggests that Cu-MOFs offer promising benefits in promoting cell migration, angiogenesis, and collagen deposition. They achieve continuous release of Cu
2+ ions, thereby reducing Cu
2+ cytotoxicity and aiding in the healing process of diabetic wounds. However, the therapeutic potential of current MOF carriers is restricted due to their limited tissue penetration, as they only interact with the surface of the wound [
82]. NO deficiency in wound healing slows collagen deposition collagen and weakens wounds. Studies highlight boosting or supplying NO to reduce swelling, foster blood vessels, and accelerate collagen synthesis [
83]. The MOF, with unsaturated metal sites, tightly binds NO. Zhang
et al. synthesized NO@HKUST-1 by modifying 4-(methylamino)pyridine and introducing NO under pressure. This approach combined HKUST-1's amine groups with NO for controlled loading, showing synergistic effects of NO and Cu
2+ on angiogenesis, collagen enhancement, and inflammation reduction at wound sites [
84]. Cobalt ions have the potential to stabilize hypoxia and stimulate angiogenesis by stabilizing hypoxia-inducible factor 1
α (HIF-1
α) [
85]. They are often used in biomaterials to promote vascularization. Co-MOF can serve as both a drug carrier and Co ion release system [
86]. Li
et al. devised a controlled release system, incorporating ZIF-67-loaded nanoparticles into micropatterned poly(l-lactic acid) (PLLA)/gelatin nanofibrous scaffolds for prolonged angiogenic therapy in diabetic wound beds.
In vitro studies suggest that Co ions and dimethylallyl glycine (a pro-angiogenic agent) released from specific nanofiber scaffolds enhance tube formation, migration, and growth of human umbilical vein endothelial cells (HUVECs). This effect is linked to increased VEGF, HIF-1
α, and endothelial nitric oxide synthase (eNOS), inducing a hypoxic response.
In vivo experiments demonstrate that these scaffolds promote collagen deposition, and angiogenesis, and reduce inflammation in diabetic wounds [
87]. Hypomagnesemia has been associated with insulin resistance and heightened platelet reactivity, factors that might elevate the susceptibility to diabetic foot ulcers [
88]. Magnesium exhibits promising pro-angiogenic properties [
89]. Furthermore, recent studies demonstrated that macrophages exposed to magnesium demonstrated heightened expression of the M2 subtype and increased secretion of anti-inflammatory cytokines. This suggests that Mg(Ⅱ) could potentially function as a novel anti-inflammatory agent [
90]. Yin
et al. developed a multifunctional magnesium organic framework-graphene oxide-silver microneedle patch (MN-MOF-GO-Ag) based on Mg-MOFs to expedite diabetes healing. These MOFs released Mg(Ⅱ) and gallic acid gradually in acidic environments. Mg(Ⅱ) encouraged angiogenesis and regulated inflammation, while gallic acid countered intracellular ROS and reduced macrophage inflammation. MN-MOF-GO-Ag exhibited high efficacy in wound healing, attributed to its combined effects of promoting angiogenesis, antioxidation, and antibacterial activity [
91]. Zinc ions, and zinc oxide play a significant role in skin regeneration, promoting wound healing. Deficiency in zinc is linked to delayed wound recovery, contrasting previous studies confirming zinc's efficacy in healing thermal injuries [
92]. Zinc positively impacts wound healing by enhancing platelet activity for [
93], promoting angiogenesis [
94] and regulating extracellular protein expression[
95]. For wound healing and skin regeneration, Zn-MOFs serve as effective antibacterial agents due to zinc's biocompatibility and non-accumulative nature in the body. Chen
et al. synthesized Zn-MOFs (Zn-BTC)
via a solvothermal method. In experimental test, Zn-BTC exhibited prolonged zinc ion release and superior antibacterial effects. In a wound infection model involving methicillin-resistant bacteria, the Zn-BTC scaffold displayed accelerated wound healing, retaining only 6 % of the wound area by day 14, while the control group retained about 26 % [
96].